Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- SHL.F
- Price
- 51.08
- Stock movement up
- +0.16 (0.31%)
- Company name
- Siemens Healthineers AG
- Exchange
- (F ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Market cap
- 57.17B
- Ent value
- 82.30B
- Price/Sales
- 2.56
- Price/Book
- 3.13
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 49.91%
- Trailing P/E
- 29.44
- Forward P/E
- -
- PEG
- -
- EPS growth
- 2.06%
- 1 year return
- -2.70%
- 3 year return
- -4.25%
- 5 year return
- 4.75%
- 10 year return
- -
Last updated: 2025-01-17
DIVIDENDS
SHL.F does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 29.44 |
| Price to OCF | 20.23 |
| Price to FCF | 26.84 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.56 |
| Price to Book | 3.13 |
| EV to Sales | 3.68 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 1.12B |
| EPS (TTM) | 1.74 |
| FCF per share (TTM) | 1.90 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 22.36B |
| Gross profit (TTM) | 8.47B |
| Operating income (TTM) | 2.81B |
| Net income (TTM) | 1.94B |
| EPS (TTM) | 1.74 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 37.87% |
| Operating margin (TTM) | 12.56% |
| Profit margin (TTM) | 8.68% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.68B |
| Net receivables | 4.48B |
| Total current assets | 14.44B |
| Goodwill | 17.66B |
| Intangible assets | 7.06B |
| Property, plant and equipment | 0.00 |
| Total assets | 46.05B |
| Accounts payable | 2.13B |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 11.57B |
| Total liabilities | 27.81B |
| Shareholder's equity | 18.25B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 2.83B |
| Capital expenditures (TTM) | 696.00M |
| Free cash flow (TTM) | 2.13B |
| Dividends paid (TTM) | 1.06B |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 10.64% |
| Return on Assets | 4.22% |
| Return on Invested Capital | 10.64% |
| Cash Return on Invested Capital | 11.67% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 50.92 |
| Daily high | 51.08 |
| Daily low | 50.92 |
| Daily Volume | 0K |
| All-time high | 67.68 |
| 1y analyst estimate | 59.56 |
| Beta | 0.73 |
| EPS (TTM) | 1.74 |
| Dividend per share | - |
| Ex-div date | 19 Feb 2025 |
| Next earnings date | 6 Feb 2025 |
Downside potential
Loading...
Downside potential data
| SHL.F | S&P500 | |
| Current price drop from All-time high | -24.53% | -2.47% |
| Highest price drop | -39.51% | -56.47% |
| Date of highest drop | 27 Sep 2022 | 9 Mar 2009 |
| Avg drop from high | -14.83% | -11.11% |
| Avg time to new high | 26 days | 12 days |
| Max time to new high | 790 days | 1805 days |
COMPANY DETAILS
Marketcap
57.17B
Marketcap category
Large-cap
Description
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company was incorporated in 2017 and is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Employees
72300
Investor relations
-
SEC filings
CEO
Country
Germany
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
It's been a good week for Siemens Healthineers AG ( ETR:SHL ) shareholders, because the company has just released its...
November 29, 2024
The latest investor updates on stocks that are trending on Thursday.
November 14, 2024
Siemens Healthineers(XTRA:SHL) has reported a strong financial performance with a notable increase in earnings and sales for the fiscal year 2024, reflecting the company's effective business strategie...
November 13, 2024
Siemens Healthineers ( ETR:SHL ) Full Year 2024 Results Key Financial Results Revenue: €22.4b (up 3.2% from FY 2023...
November 11, 2024
It's been a good week for Siemens Healthineers AG ( ETR:SHL ) shareholders, because the company has just released its...
November 10, 2024
Earnings preview of key companies reporting next week and what to look out for.
November 8, 2024
The German healthcare company posted lower-than-expected net profit and revenue, despite a rise in sales.
November 6, 2024
Key Insights Significant control over Siemens Healthineers by public companies implies that the general public has more...
November 5, 2024
Earnings preview of key companies reporting this week and what to look out for.
November 1, 2024
TARRYTOWN, N.Y., October 15, 2024--A new prognosis claim for the Siemens Healthineers Atellica IM High-Sensitivity Troponin I (TnIH) test1 immediately advances care for at-risk cardiac patients in the...
October 15, 2024
Next page